Please login to the form below

Not currently logged in
Email:
Password:

Actelion appoints former GSK CEO as chair

Dr Jean-Pierre Garnier, former CEO at GlaxoSmithKline, has been appointed chairman of Swiss biopharmaceutical company Actelion

Dr Jean-Pierre Garnier - ActelionDr Jean-Pierre Garnier, former CEO at GlaxoSmithKline (GSK), has been appointed chairman of Swiss biopharmaceutical company Actelion.

He will take over from Robert Cawthorn who will remain in the role until the company's annual general meeting in 2012.

Garnier was first appointed to Actelion's board of directors at the company's annual general meeting on May 5, 2011.

His previous positions include the CEO of GSK following the merger of SmithKline Beecham and Glaxo Wellcome in 2001. He remained at GSK until 2008 when he became CEO of French pharmaceutical and cosmetics company Pierre Fabre Labs.

Prior positions at SmithKline Beecham include president of the company's pharmaceutical business in North America, as well as chairman of its pharmaceuticals division and chief operating officer.

Jean-Paul Clozel, co-founder and CEO of Actelion, described Garnier as "one of the world's most renowned pharma managers" following the announcement.

He said: "He is the right person to lead Actelion into the next stage of the company's development."

28th September 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Rainmaker Healthcare Communications

Rainmaker is an independent, award-winning communications agency with offices in London and Atlanta. Our experience across pharmaceuticals, generics, OTC, medical...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics